report

November 17, 2017November 17, 2017

Nurses, Physicians’ Assistants Prescribe Antibody-based Therapies More Than Neurologists, Survey Shows

News

U.S. nurses and physicians’ assistants prescribe antibody-based disease-modifying therapies to their multiple sclerosis patients more than neurologists do, a survey indicates. The trend has been for the ... Read more

November 2, 2017November 2, 2017

#MSParis2017 – Almost Half of MS Patients Fail to Report Relapses, Two Surveys Show

News

Nearly half of multiple sclerosis patients do not always report their relapses to healthcare providers, two surveys indicate. Mallinckrodt sponsored the surveys to better understand patients’ experience with ... Read more

September 28, 2017September 27, 2017

A Look Inside MS Marketplace Projections

Columns, Engaging Thoughts

Do you ever stop and ponder the value of MS drugs? I’m not talking about if they work and the ways they improve our lives. I’m ... Read more

July 20, 2017July 21, 2017

Ocrevus Is Popular Among Neurologists, but Insurance Is a Growing Concern, Report Concludes

News

Ocrevus’ market introduction is off to a stellar start, with nearly half of neurologists surveyed by Spherix Global Insights saying they are using the therapy — ... Read more

January 19, 2017January 19, 2017

Reports on MS Treatment Market Show Growing Shift to Oral Therapies

News

The multiple sclerosis (MS) market shifted during 2016, with oral disease-modifying therapies (DMTs) capturing a greater share and Sanofi-Genzyme’s Aubagio (teriflunomide) being poised for growth, according to ... Read more

July 18, 2016July 18, 2016

Closer Look at ICER, Group Now Weighing Efficacy and Benefits of RRMS Therapies

News

The Institute of Clinical and Economic Review (ICER), the nonprofit organization that released a preliminary draft last week intended to shape the Institute’s forthcoming report on the effectiveness and ... Read more

Pin It on Pinterest